Beth Faiman

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program, Case Comprehensive Cancer Center
Cleveland, Ohio

Attend Events by Beth Faiman

Explore Activities by Beth Faiman

Title
Format
Credit Type
Credits
CAR T-Cell Therapy in Multiple Myeloma: Understanding and Communicating Current Evidence for CAR T-Cell Therapy

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

0.75
CAR T-cell Therapy in Multiple Myeloma: Referrals and Care Coordination to CAR T-Cell Treatment Centers

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

0.50
CAR T-Cell Therapy in Multiple Myeloma: Understanding and Communicating Safety Evidence

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

0.75
CAR T-Cell Therapy in Multiple Myeloma: Understanding and Communicating Current Evidence

Content Format:

Slideset

Credit Type:

--

Credits:

--
CAR T-Cell Therapy in Multiple Myeloma: Understanding and Communicating Safety Evidence

Content Format:

Slideset

Credit Type:

--

Credits:

--
CAR T-Cell Therapy in Multiple Myeloma: Referrals and Care Coordination to CAR T-Cell Treatment Centers

Content Format:

Slideset

Credit Type:

--

Credits:

--
Point-of-Care, Digital, Interactive Decision Support Tool (IDST) for the Prevention/Management of AEs During Treatment with BsAbs in MM

Content Format:

Tool

Credit Type:

--

Credits:

--
Practical Implementation of CAR T-Cell Therapy in Lymphomas: Key Points for Advanced Practice Providers

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Bispecific Antibodies Across Hematologic Malignancies: Nursing Considerations and Skill-Based Training for Clinical Integration

Content Format:

Video

Credit Type:

ANCC

Credits:

0.75
Early Referrals and Care Coordination to CAR T-Cell Treatment Centers

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

0.50
Bispecific Antibodies Across Hematologic Malignancies: Nursing Considerations and Skill-Based Training for Clinical Integration

Content Format:

Slideset

Credit Type:

ANCC

Credits:

1.00
Understanding and Communicating Current Evidence for CAR T-Cell Therapy in Lymphomas

Content Format:

Slideset

Credit Type:

--

Credits:

--
Understanding and Communicating Safety Evidence With CAR T-Cell Therapy in Lymphomas

Content Format:

Slideset

Credit Type:

--

Credits:

--
Early Referrals and Care Coordination to CAR T-Cell Treatment Centers

Content Format:

Slideset

Credit Type:

--

Credits:

--
APPlexus Hot Topics 2024: Advances in Targeted Therapeutics for Biliary Tract Cancer

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

1.00
Next-Generation Care for Patients With Bladder Cancer

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

1.00
APPlexus Hot Topics 2024: Clinical Updates on Non-Covalent BTK Inhibitors in CLL and MCL

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

1.00
Immunotherapy, Bispecific Platforms, and CD38 Antibodies in Myeloma: Optimizing Treatment & Enhancing Access

Content Format:

Slideset

Credit Type:

--

Credits:

--
Clinic-Ready Insights From ASH 2023: MPNs

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

1.00
Clinic-Ready Insights From ASH 2023: MCL and CLL

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

1.00
BTK Inhibitors in CLL/SLL and MCL: The Latest Guidance and Evidence for the Clinic

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Current and Novel Approaches to the Management of Patients With CLL/SLL and MCL Using BTK Inhibitors

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Current and Emerging Novel Approaches to the Management of Patients with CLL/SLL and MCL

Content Format:

Slideset

Credit Type:

--

Credits:

--